Involvement of CB1-receptors and β-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Gardiner, S M ^a,b   March, J E ^a   Kemp, P A ^a   Bennett, T ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

AM 251; Endotoxemia; Vasodilatation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA ADRENERGIC RECEPTOR; CANNABINOID; CANNABINOID 1 RECEPTOR; LIPOPOLYSACCHARIDE; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PIPERIDINE DERIVATIVE; PROPANOLAMINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; ENDOTOXEMIA; HEART RATE; HEMODYNAMIC MONITORING; KIDNEY BLOOD FLOW; LIMB BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; TACHYCARDIA; VASODILATATION; ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CONSCIOUSNESS; DISEASE MODEL; DRUG ANTAGONISM; DRUG INTERACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CONSCIOUSNESS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENDOTOXEMIA; LIPOPOLYSACCHARIDES; MALE; PIPERIDINES; PROPANOLAMINES; PROPRANOLOL; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, BETA; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA; VASODILATION;

EID: 18044382538     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00851.2004     Document Type: Article

References (39)

1. 2 receptors. Am J Physiol Heart Circ Physiol 287: H595-H600, 2004.
2. 2-selective adrenoceptor antagonist (ICI 118551). J Cardiovasc Pharmacol 5: 430-437, 1983.
3. Blair R, Fishman B, Amit Z, and Weeks JR. A simple double channel swivel for infusion of fluids into unrestrained animals. Pharmacol Biochem Behav 12: 463-466, 1980.
4. 2-adrenergic receptor stimulation inhibits nitric oxide generation by Mycobacterium avium infected macrophages. J Neuroimmunol 101: 68-75, 1999.
5. Chi DS, Qui M, Krishnaswamy G, Li C, and Stone W. Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 8: 127-132, 2003.
6. 1 receptors and tumor necrosis factor-α in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents. Br J Pharmacol 140: 115-122, 2003.
7. Evans EB, Seifen E, Kennedy RH, Kafiluddi R, Paule MG, Skallet AC, Ali SF, and Slikker W. Effects of chronic delta-9-THC treatment on cardiac beta-adrenoceptors in rats. Pharmacol Biochem Behav 28: 171-174, 1987.
8. Ford WR, Honan SA, White R, and Hiley CR. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts. Br J Pharmacol 135: 1191-1198, 2002.
9. Gardiner SM, Kemp PA, March JE, and Bennett T. Cardiac and regional hemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol 116: 2005-2016, 1995.
10. Gardiner SM, Kemp PA, March JE, and Bennett T. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats. Br J Pharmacol 119: 1619-1627, 1996.
11. Gardiner SM, Kemp PA, March JE, Woolley J, and Bennett T. The influence of antibodies to TNF-α and IL-1β on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Br J Pharmacol 125: 1543-1550, 1998.
12. Gardiner SM, Kemp PA, March JE, and Bennett T. Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol 128: 1772-1778, 1999.
13. 1) receptor antagonist, AM 251, on the regional haemodynamic responses to lipopolysaccharide infusion in conscious Sprague-Dawley rats (Abstract). Br J Pharmacol 138, Suppl: 68P, 2003.
14. Gardiner SM, March JE, Kemp PA, and Bennett T. Influence of CGRP (8-37), but not adrenomedullin (22-52), on the haemodynamic responses to lipopolysaccharide in conscious rats. Br J Pharmacol 127: 1611-1618, 1999.
15. Gardiner SM, March JE, Kemp PA, and Bennett T. Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol 135: 1889-1896, 2002.
16. 1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN 55212-2 or HU 210 in conscious rats. Br J Pharmacol 136: 581-587, 2002.
17. 1 receptors. Eur J Pharmacol 307: 331-338, 1996.
18. Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, and Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM 251 to rodent brain cannabinoid receptors. Life Sci 61: PL191-PL197, 1997.
19. 1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats. Br J Pharmacol 142: 701-708, 2004.
20. Gulmarães S and Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 53: 319-356, 2001.
21. Haskó G and Szabó C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol 56: 1079-1087, 1998.
22. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, and Kunos G. Cannabinoid-induced mesenteric vasodilatation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96: 14136-14141, 1999.
23. Kawarai M and Koss MC. Neurogenic cutaneous vasodilation the cat forepaw. J Auton Nerv Syst 37: 39-46, 1992.
24. 1-adrenoceptors. Eur J Pharmacol 386: 227-233, 1999.
25. Landry DW and Oliver JA. The pathogenesis of vasodilatory shock. New Engl J Med 345: 588-595, 2001.
26. Parrillo JE. Pathogenetic mechanisms of septic shock. New Engl J Med 328: 1471-1478, 1993.
27. Pfitzer T, Niederhoffer N, and Szabo B. Central effects of the cannabinoid receptor agonist WIN 55212-2 on respiratory and cardiovascular regulation in anaesthetised rats. Br J Pharmacol 142: 943-952, 2004.
28. Randall MD, Kendall DA, and O'Sullivan S. The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol 142: 20-26, 2004.
29. Rogausch H, Vo NT, Del Rey A, and Besedovsky HO. Increased sensitivity of the baroreceptor reflex after bacterial endotoxin. Ann NY Acad Sci 917: 165-168, 2000.
30. Schaller MD, Waeber B, Nussberger J, and Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol Heart Circ Physiol 249: H1086-H1092, 1985.
31. Smith SR, Terminell C, and Denhardt G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatroy interleukin-10 in endotoxemic mice. J Pharmacol Exp Ther 293: 136-150, 2000.
32. Theodorsson-Norheim E. Friedman and Quade test: BASIC computer program to perform non-parametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med 17: 85-99, 1987.
33. Varga K, Wagner JA, Bridgen T, and Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12: 1035-1044, 1998.
34. Wagner JA, Hu K, Bauersach J, Karcher J, Wiesler M, Goparaju SK, Kunos G, and Ertl G. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 38: 2048-2054, 2001.
35. 1 cannabinoid receptors in haemorrhagic shock. Nature 390: 518-521, 1997.
36. Waller J, Gardiner SM, and Bennett T. Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br J Pharmacol 112: 1057-1064, 1994.
37. Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M, Shímizu H, Matsuo S, Imaizumi H, and Maruyama I. Simultaneous measurement of anandamide and 2-arachindonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal Biochem 294: 73-82, 2001.
38. Woolard J, Bennett T, Dunn WR, Heal DJ, Aspley S, and Gardiner SM. Acute cardiovascular effects of sibutramine in conscious rats. J Pharmacol Exp Ther 308: 1102-1110, 2004.
39. Zhou ZZ, Wurster RD, and Jones SB. Arterial baroreflexes are not essential in mediating sympathoadrenal activation in conscious endotoxic rats. J Auton Nerv Syst 39: 1-12, 1992.